Serum-free culture medium and culture method of CAR-T cells
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A serum-free medium and culture method technology, applied in cell culture active agents, animal cells, culture process and other directions, can solve the problems affecting the cost of treatment of patients, and achieve the effect of improving cell survival rate, easy implementation and reducing culture cost.
Pending Publication Date: 2021-12-21
曾献芳
View PDF0 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Therefore, it is necessary to culture and expand a large number of CAR-T cells in vitro. Generally, a patie...
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0021] A Car-T cell-free-serum-free medium, which consists of X-Vivo 15 medium and the following components added to the medium: Ni Miao, 2.8 ng / ml, eprotcharin 8.2 ng / ml, ferulic acid ester 9.4 ng / mL, IL-2 150IU / mL, IL-15400 IU / mL, vitamin E 25 μg / ml, L-glutamine 15 μg / ml.
[0022] A CAR-T cell culture method, which encases the obtained CAR-T cells and the same amount of CD3 / CD28 magnetic beads, CAR-T cells concentration in medium in the medium 3 × 10 6 / Ml, at 37 ° C, 5% CO 2 The culture tank was cultured for 10 days, and a medium was supplemented once every 1 day during the culture.
Embodiment 2
[0024] A car-T cell-free-serum-free medium, which consists of X-Vivo 15 medium and the following ingredient added to the medium: Ni Miao, 2.8 ng / ml, Epiracein 6.8 ng / ml, ferulicate 8.5 ng / ml, IL-2 100 IU / mL, IL-15300 IU / mL, vitamin E 20 μg / mL, L-glutamine 10 μg / ml.
[0025] A CAR-T cell culture method, which encases the obtained CAR-T cells and the same amount of CD3 / CD28 magnetic beads, CAR-T cells concentration in medium in the medium 1 × 10 6 / Ml, at 37 ° C, 5% CO 2 10 days were cultured in the incubator, and a medium was supplemented every 2 days during the culture.
Embodiment 3
[0027] A car-T cell-free-serum-free medium, which consists of x-Vivo 15 medium and the following ingredient added to the medium: nigerin 3.5 ng / ml, eprotcharin 9.6 ng / ml, ferulicate 10 ng / ml, IL-2 200 IU / mL, IL-15500 IU / mL, vitamin E 30 μg / ml, L-glutamine 18 μg / ml.
[0028] A CAR-T cell culture method, which disseptes the obtained CAR-T cells and the same amount of CD3 / CD28 magnetic beads were added to the medium of T75 culture flasks, and CAR-T cells concentrated in the medium to 5 × 10 6 / Ml, at 37 ° C, 5% CO 2 The culture tank was cultured for 10 days, and a medium was supplemented once every 1 day during the culture.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a serum-free culture medium of CAR-T cells. The serum-free culture medium consists of a basic culture medium and the following components added into the culture medium: nicergoline, icariin, ferulate, IL-2, IL-15, vitamin E and L-glutamine. The nicergoline and the icariin are added into the serum-free culture medium of the CAR-T cells in the invention, so that the proliferation activity of the CAR-T cells can be effectively improved; and a large number of CAR-T cells can be harvested within a short time. The ferulate is also added, so that the number of living cells in the harvested cells is easily increased; and the cell survival rate is increased. The components, the L-2, the IL-15, the vitamin E and the L-glutamine jointly act; the proliferation activity of the CAR-T cells is improved; the used components are safe; blood components such as plasma are not added; the culture cost of the CAR-T cells is reduced; and the burden of a patient is relieved. The invention further provides a culture method of the CAR-T cells; the culture method is simple and convenient to operate and easy to implement; and popularization and application of the CAR-T cells in the field of tumour immunotherapy are facilitated.
Description
Technical field [0001] The present invention relates to the field of immunocytes, and in particular, to a CAR-T cell-free medium serum-free medium and a culture method thereof. Background technique [0002] T cells are also called T lymphocytes, one of human white blood cells, originated from bone marrow hematopoietic stem cells, matures in the thymus, then moved to human blood, lymphoid tissue organs, and play immune function. Its role is equivalent to the "warrior" in the human body, which can resist and destroy "enemy" such as infection, tumor, foreign foreign matter. [0003] As the T lymphocyte tumor immune response mechanism is increasingly attached, chimeric antigen receptor T (CAR-T) cell therapy is a new immunotherapy strategy in the field of tumor immunotherapy. In the laboratory, technicians are activated by genetic engineering techniques, and they are attached to the positioning device Car (tumor chimeric antigelastic receptor), and CAR-T cell therapy is a new precisi...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more